UBS’s HI-TECH PHARMACAL INC HITK Stock Holding History

UBS’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-500	Closed	-$22K	–	11358
2014 Q1	$22K	Sell	500 -1,412	-74%	-$61.2K	﹤0.01%	7991
2013 Q4	$83K	Sell	1,912 -2,777	-59%	-$120K	﹤0.01%	6309
2013 Q3	$203K	Buy	4,689 +3,055	+187%	+$117K	﹤0.01%	5164
2013 Q2	$54K	Buy	+1,634	New	+$54.4K	﹤0.01%	6639

UBS's HITK Position: Q2 2014 in Review

UBS sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 500 shares — an estimated $22K sold.

UBS first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $203K in Q3 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

UBS reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
UBS sold 500 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $22K.
UBS first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
UBS's HI-TECH PHARMACAL INC position peaked at $203K in Q3 2013.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.